Report Highlights

France Veterinary CT Scanner Market: Market Overview

The French veterinary CT scanner market was valued at USD 18.6 million in 2024, supported by a dense network of referral veterinary hospitals, four accredited national veterinary schools, and a growing private equity-backed consolidation of multi-specialty clinics. France holds the second-largest companion animal population in the European Union, with over 15 million cats and 7.5 million dogs registered, creating sustained clinical demand for advanced cross-sectional imaging. Government funding channelled through public veterinary universities has historically been the primary procurement driver, though private referral groups now account for over 40% of new CT placements annually.

The market structure is shaped by a dual-track procurement environment: publicly funded veterinary schools operate under the Agence Nationale de la Recherche and Ministère de l'Agriculture capital equipment frameworks, while private clinics access equipment through commercial leasing and bank financing. The four national veterinary schools — VetAgro Sup Lyon, EnvA Maisons-Alfort, ENVT Toulouse, and Oniris Nantes — function as technology anchors, typically adopting premium multi-slice CT systems that influence purchasing decisions across affiliated regional referral networks. Private sector growth, accelerated by IVC Evidensia's French acquisitions since 2021, is progressively shifting the demand centre of gravity toward medium-bore, fast-cycle scanners optimised for high-throughput companion animal work.

Policy-Driven Growth in French Veterinary CT Scanners

Three policy mechanisms are directly expanding demand for veterinary CT scanners in France. First, the Loi Égalim 2 (Law No. 2021-1357), while focused on food chain transparency, introduced traceability mandates for production animals that have elevated diagnostic imaging standards in veterinary referral chains, indirectly creating demand for CT-based pathology confirmation in food-chain clinical audits. Second, the France Relance recovery plan allocated EUR 1.1 billion to research infrastructure modernisation, with the Ministère de l'Enseignement Supérieur directing a portion toward biomedical and veterinary equipment upgrades at public universities; all four national veterinary schools submitted capital equipment claims under this scheme between 2021 and 2023, with CT scanner replacements explicitly listed in procurement notices published on the BOAMP platform.

Third, the French Autorité de sûreté nucléaire (ASN) updated its regulatory framework for ionising radiation use in non-human diagnostics under Décret No. 2018-437, which mandates three-yearly justification reviews for all veterinary CT installations. This compliance requirement functions as an indirect market driver: clinics with outdated equipment face escalating justification burdens, incentivising replacement with modern low-dose systems that clear ASN thresholds more easily. ASN's 2024 enforcement bulletin cited 14 veterinary CT installations as non-compliant with dose optimisation standards, each representing a near-term replacement procurement opportunity. The combination of these three policy levers creates a structured, policy-reinforced replacement cycle rather than purely discretionary capital spending.

Regulatory Barriers and Compliance Costs

The primary regulatory barrier for veterinary CT scanners in France is the requirement to comply with the EU Medical Device Regulation (MDR) 2017/745 for human-grade systems repurposed in veterinary settings, enforced domestically by the Agence nationale de sécurité du médicament et des produits de santé (ANSM). Suppliers repurposing Class IIb or Class III human CT systems for veterinary use must maintain post-market surveillance documentation under MDR Article 83, a process that adds six to twelve months to deployment timelines and imposes ongoing vigilance reporting costs estimated at EUR 45,000 to EUR 80,000 per device family annually. Purpose-built veterinary CT units marketed under general product safety legislation escape this burden but must still register with ANSM's veterinary medical device notification scheme, which carries a 90-day review window.

Radiation protection compliance under ASN's Décision No. 2013-DC-0349 imposes specific installation requirements — including dedicated shielded rooms meeting 2.5mm lead-equivalent standards, dosimetry programmes for operators, and mandatory appointment of a Personne Compétente en Radioprotection (PCR) — which collectively add EUR 120,000 to EUR 250,000 to the total cost of a new CT installation depending on facility configuration. The PCR requirement, administered under the Institut de Radioprotection et de Sûreté Nucléaire (IRSN) certification framework, creates a recurring personnel cost that smaller independent veterinary clinics find prohibitive, effectively concentrating CT ownership among referral hospitals and university clinics. Local content rules do not apply, but procurement for public veterinary institutions must comply with the Code de la commande publique, requiring open tendering above EUR 215,000, which extends procurement cycles by an average of four to six months.

Policy-Created Opportunities in France

France's Plan France 2030, launched by the Élysée in October 2021 with EUR 30 billion in innovation spending, includes a dedicated biohealth innovation stream that funds research platforms at accredited veterinary and biomedical institutions. The Bpifrance-administered Equipex+ programme, which extended its call for infrastructure applications through 2025, has approved multimodal imaging platforms at two veterinary research consortia, each incorporating small-animal CT as a core modality. Suppliers capable of integrating CT with PET or MRI outputs into unified software platforms are positioned to capture this procurement wave, as Equipex+ grants require interoperability documentation that favours integrated system vendors over standalone CT manufacturers.

A second structural opportunity arises from the French government's One Health (Une Seule Santé) national strategy, formalised through the Interministerial Plan 2022–2026 co-signed by the Ministère de la Santé and the Ministère de l'Agriculture. This strategy explicitly funds comparative medicine research programmes that require cross-species CT imaging datasets, creating grant-backed procurement demand at university veterinary hospitals and INRAE research stations. Additionally, ASN's forthcoming revision of veterinary radiation standards, anticipated in 2026, is expected to mandate digital dose management systems as a condition of installation approval — opening a dedicated software and upgrade market currently worth an estimated EUR 3.5 million annually that will expand sharply once the regulatory deadline is confirmed.

Market at a Glance

Leading Market Participants

• Siemens Healthineers
• Canon Medical Systems
• GE HealthCare
• Epica Medical Innovations
• Hallmarq Veterinary Imaging
• Philips Healthcare
• Animage
• NeuroLogica (Samsung)
• Toshiba Medical (Canon legacy)
• Varex Imaging

Regulatory and Policy Environment

The centrepiece legislation governing veterinary CT scanner use in France is Décret No. 2018-437 du 5 juin 2018 relatif à la protection des travailleurs contre les risques dus aux rayonnements ionisants, implemented domestically under the authority of ASN and IRSN. This decree transposes EU Directive 2013/59/Euratom into French law and sets binding operational requirements for veterinary radiological installations, including mandatory justification of each CT examination, dose optimisation protocols aligned with ALARA principles, and facility-level radiation protection programmes. ANSM holds parallel authority over medical device market surveillance, including repurposed CT equipment, and coordinates with ASN on dual-regulated installations. Compared to Germany, where the Strahlenschutzgesetz applies primarily to human medicine and veterinary CT regulation remains fragmented across Länder, France's centralised ASN oversight provides a more predictable but administratively heavier compliance environment.

Upcoming regulatory changes include ASN's scheduled revision of Décision No. 2013-DC-0349 in 2026, which is expected to introduce mandatory digital dose area product recording for all veterinary CT examinations, requiring software upgrades across an estimated 85 installed systems nationally. The European Commission's review of MDR transitional provisions under Article 120, currently anticipated to conclude in 2027, will determine whether legacy human-grade CT systems in veterinary use must undergo full MDR conformity assessment — a change that would accelerate replacement procurement for the estimated 60% of French veterinary CT installations using pre-MDR certified equipment. France has already submitted formal commentary to the European Commission through the ANSM's Medical Devices Expert Group advocating for a veterinary-specific sub-regulatory pathway, a position that, if adopted, would significantly reduce compliance costs for purpose-built veterinary system manufacturers.

Long-Term Policy Outlook for French Veterinary CT Scanners

By 2032, three policy trajectories will reshape the French veterinary CT scanner market. The One Health interministerial strategy's 2026 mid-term review is expected to increase funding allocations for comparative medicine infrastructure, directing additional capital toward INRAE and university veterinary hospital imaging suites. France's EU Council Presidency priorities in the 2026–2028 cycle are expected to advance a harmonised EU veterinary medical device regulation framework, which France has championed; if enacted, this would remove the ANSM dual-registration burden and reduce market entry costs, increasing the number of active vendors from the current six to an estimated nine or ten by 2030, intensifying price competition in the mid-tier scanner segment.

The anticipated 2026 ASN dose management mandate will function as a forced technology refresh, compelling owners of installed base systems manufactured before 2018 — representing an estimated 38 units nationally — to either upgrade software or replace hardware entirely. This creates a compressed procurement window between 2026 and 2028 that suppliers should treat as a discrete revenue event, not a gradual trend. Beyond this, the French government's ambition under Plan France 2030 to make France the leading European hub for veterinary biomedical innovation will sustain above-average public procurement spending in this segment through the forecast period, maintaining France's position as the second-largest veterinary CT market in Western Europe after Germany.